Katherine Green - July 9, 2025 Most opposed companies at the EPO in 2024 Opposition activity at the European Patent Office is often a strong indicator of a technology’s ...
Adam Gregory - July 4, 2025 Mewburn Ellis is proud to have worked on 24 of the 100 top-selling pharmaceuticals of 2024 Mewburn Ellis works with some of the world’s most important pharmaceuticals and biologics across a ...
Sarah Harvey - June 30, 2025 Optimising Training for the Menstrual Cycle In recent years, there's been a noticeable shift in how we approach female athletic performance, ...
Eliot Ward - June 30, 2025 Mewburn Ellis Extends BII Residency, Deepening Support for Denmark’s Innovation Ecosystem Mewburn Ellis is pleased to announce that we have extended our residency at the BioInnovation ...
Katherine Green - June 30, 2025 Most opposed patents of 2024 The list is, again, dominated by patents for therapeutic treatments, although the trends seen last ...
Eliot Ward - June 27, 2025 BluMaiden: Pioneering AI-Driven Precision in Immunotherapy Response Prediction BluMaiden uses AI and microbiome insights to boost immunotherapy prediction and speed up drug ...
Sarah Harvey - June 25, 2025 Combatting AMR in UTIs Urinary tract infections (UTIs) are among the most common bacterial infections, affecting millions ...
Christopher Casley - June 24, 2025 Next Generation ADCs at AACR25 The American Association of Cancer Research (AACR) Annual Meeting is a critical driver of progress ...
Calum Graham - June 20, 2025 Building a Future on Synthetic Biology Concrete, insulation, cladding—these materials form the skeleton of our built environment, however ...
Louise Atkins - June 18, 2025 Brazil to join the Budapest Treaty On 11 June 2025, the Brazilian Senate approved the country’s accession to the Budapest Treaty1 — an ...
Katherine Collins - June 13, 2025 Gene Therapy and Longevity: Transforming the Future of Healthy Aging Building on the success of gene therapies in treating rare diseases, the field is now rapidly ...
Nick Sutcliffe - June 11, 2025 5 reasons intellectual property is important for food-tech start-ups Many food-tech start-ups we speak with say they're not too concerned about intellectual property. ...
Ben Tolley - June 10, 2025 A Boost for Sustainable Agriculture: The Promise of the US “Plant Biostimulant Act” In a welcome development for sustainable agriculture, United States Representatives Jimmy Panetta ...
Fay Allen - June 10, 2025 New treatments for women’s pain In a previous blog we discussed the gender pain gap and how attitudes and access to treatment of ...
Fay Allen - June 3, 2025 Why women’s health is such a pain: the gender pain gap Many women’s health conditions are associated with pain, for example dysmenorrhea (period pain), ...
Katie Dale - May 21, 2025 Couriers for Cures: The Next Generation of Delivery Methods for Gene Therapy A record number of gene therapies achieved regulatory approval in 2024, transforming how biopharma ...
Calum Graham - May 8, 2025 Bioglass and bio-microlenses: synthetic biology’s leap into optics Synthetic biology continues to blur the lines between natural and man-made materials. Recently we ...
Isabelle Murray - May 7, 2025 AI speaking the language of life will produce life-saving gene therapies (not memes)! Expression constructs are among the most widely used tools in modern biological research. These ...
Andrew Pitts - May 2, 2025 Biohaven secures $600M investment to advance life-changing therapies, including for spinocerebellar ataxia We extend a big congratulations to our client, Biohaven Ltd., on recently entering into an ...
Jennifer Hoang - April 28, 2025 A new sequencing technology extends the NGS revolution Completed in 2003, the first human genome sequence took 13 years to finish and cost approximately ...
Emily Garnett - April 24, 2025 Collecting Birthdays: Unveiling the Secrets of Extreme Human Longevity When 117-year-old, Maria Branyas Morera died in August last year, she was the world’s oldest living ...
Nick Sutcliffe - April 17, 2025 The Easter Bunny in a white coat — lab-grown chocolate As Easter approaches, chocolate takes centre stage. Across the world, people look forward to ...
Emily Garnett - April 9, 2025 Seeing double: the rise of biparatopic antibodies It’s no secret that antibody therapies are gaining ever-increasing popularity in the pharmaceutical ...
Adam Gregory - April 3, 2025 Crafting IP Strategies for Innovative Biotechs Following his conversation with John Joson Ng for Nucleate Singapore Pulse, we speak to Adam ...
Simon Kremer - March 28, 2025 Enzyme engineering with AI – the latest chapter (in a long story…) For those of us who studied Biochemistry at college, the classic active site “catalytic triad” of ...
Simon Kremer - March 25, 2025 HutanBio: algae is the fuel of the future Algae converts sunlight and carbon dioxide into flammable hydrocarbons, offering a like-for-like ...
Adam Gregory - March 19, 2025 In vivo Cell Therapy: Breaking Free of the Chains of Ex Vivo Engineering In vivo cell therapy is emerging as a groundbreaking approach to reduce the cost and expand the ...
Rebecca Tollervey - March 11, 2025 Innovations in antibody-drug conjugates and bispecific antibodies – what you need to know - a new special report We are delighted to release our latest report Innovations in antibody-drug conjugates and ...
Edward Couchman - March 11, 2025 Discontinuous Epitope Claims get Green Light in Europe Patents for antibodies defined by discontinuous epitopes have garnered a lot of attention recently. ...
Adam Gregory - March 7, 2025 Hummingbird Bioscience’s multi-payload ADC technology licensed by Callio Therapeutics We are delighted to congratulate our client Hummingbird Bioscience on the successful out-licensing ...
Nick Sutcliffe - March 5, 2025 UK's Alternative Protein Sector Takes Major Leap with Landmark Collaboration In a landmark move for the UK's alternative protein sector, four leading research centres - the ...
Nick Sutcliffe - March 3, 2025 Oncolytic Virotherapy (OVT) – A Technology Finally Coming of Age? The potential of viruses to selectively infect and kill cancer cells was first recognised over a ...
Joanna Smith - February 27, 2025 How AI is Shaping the Future of MedTech - a new special report We are delighted to release our latest report How AI is Shaping the Future of MedTech. View the ...
Katherine Collins - February 19, 2025 Revolutionising Immunotherapy: The Promise of TCR T-Cells For the past 10 years or so, the focus in the adoptive T-cell therapy space has been on chimeric ...
Sean Constable - February 10, 2025 Unlocking immortality: the innovations driving human longevity Science has made great strides in dramatically increasing life expectancy. In the 1900s, the ...
Adam Gregory - January 30, 2025 A Meaty Victory for Impossible Foods In decision T 0425/23 of 20 December 2024, the European Patent Office (EPO) Board of Appeal (BoA) ...
Anja Koller - January 16, 2025 The power of Bioprocess Engineering Microorganisms wield the power to revolutionise industries and address global challenges. These ...
Joanna Smith - January 14, 2025 Quantum and the law - a new special report We are delighted to release our latest report Quantum and the law. View the report here.
Eliot Ward - January 13, 2025 UPC Weekly - Alexion v Samsung & Amgen – Patentee’s attempted U-turn on claim interpretation foiled by UPC Court of Appeal 2025 Week 2 Tailoring one’s claim interpretation for the jurisdiction at hand can be a canny way of ...
Rebecca Anderson-Smith - January 13, 2025 Veganuary: can you reference the animal counterpart in the branding of your vegan product? From This Isn't Bacon Plant-Based Rashers, to Violife Smoky Cheddar Flavour Slices, a quick glance ...
Matthew Naylor - January 6, 2025 UPC Weekly - UPC transparency by numbers 2025 Week 1 How easy is it to get hold of documents from UPC cases? The easy answer “it depends” is ...
Matthew Naylor - December 30, 2025 UPC Weekly - Pay to play at the UPC 2024 Week 52 Both Apple and Google have recently succeeded in persuading the UPC Local Division ...
Matthew Naylor - December 16, 2024 UPC Weekly - The 9 second rule at the UPC 2024 Week 50 Does it matter who gets to the doors of the UPC first? Does it matter if you get there ...
Matthew Naylor - December 9, 2024 UPC Weekly - Very appealing – preliminary injunction overturned 2024 Week 49 SharkNinja have managed to persuade the UPC Court of Appeal to overturn a preliminary ...
Matthew Naylor - December 2, 2024 UPC Weekly - Front-loading and obviousness at the UPC 2024 Week 48 In NJOY v VMR, the UPC Central Division Paris revoked VMR’s patent EP 3456214 B2 on 27 ...
Matthew Naylor - November 25, 2024 UPC Weekly - UPC finds infringement using a doctrine of equivalents 2024 Week 47 Back in June 2024 (UPC Weekly 2024 week 23), we set out a few “known unknowns” – ...
Emily Lythell - November 21, 2024 Resistance is futile – how new tech tackles AMR Antimicrobial resistance (AMR) refers to the ability of microorganisms—bacteria, viruses, fungi, ...
Matthew Naylor - November 18, 2024 UPC Weekly - UPC dials up the advantages for patentees 2024 Week 46 We report this week on two new UPC decisions that make the UPC an even more attractive ...
Eliot Ward - November 13, 2024 Cambiotics: a novel treatment for PFAS ‘forever chemicals’ PFAS are toxic pollutants causing health problems globally. There is currently no treatment. Now a ...
Matthew Naylor - November 11, 2024 UPC Weekly - NJOY duel with Juul 2024 Week 45 5 November 2024 saw two decisions handed down by the UPC Paris Central Division (CD) ...
Isobel Fisher - November 11, 2024 AI designer enzymes During the announcement of the first survey of the entire human genome by the Human Genome Project, ...
Matthew Naylor - November 4, 2024 UPC Weekly - All of the fizz and none of the squeeze 2024 Week 44 SodaStream v Aarke is a decision on the merits of an infringement case based on EP ...
Camille Terfve - October 29, 2024 Alchemab: the art of AI antibody discovery Alchemab’s artificial intelligence platform enables the identification of antibodies for some of ...
Anna Mudge - October 29, 2024 GENE-ius options to protect gene therapies Gene therapies involve treating patients by manipulating their genetic makeup. Such therapies may ...
Matthew Naylor - October 28, 2024 UPC Weekly - UPC confirms approach to inventive step for life science inventions 2024 Week 43 10x Genomics and NanoString have been duking it out at the UPC since the court opened ...
Matthew Naylor - October 21, 2024 UPC Weekly - Light emitting diode patent falls into a black hole of invalidity 2024 Week 42 Last week we did a deep dive into some LED technology to explain the decision of the ...
Joanna Smith - October 17, 2024 Chambers & Partners 2025 legal guide - Band 1 We are proud to have once again been ranked Band 1 (gold) in Chambers & Partners 2025 legal ...
Matthew Naylor - October 14, 2024 UPC Weekly - A pro-patent decision on infringement and validity 2024 Week 41 This week we report on Seoul Viosys v Expert Klein, a full decision on infringement ...
Simon Kiddle - October 9, 2024 Liquid precision bandages NoBACZ ingenious new gels create an instant seal over a wound. The company is changing the way farm ...
Tom Furnival - October 8, 2024 Most opposed medical device companies at the EPO 2023 Following on from our recent post on the Most Opposed Companies at the EPO 2023 we’ve broken that ...
Matthew Naylor - October 7, 2024 UPC Weekly - Costs: the UPC’s Big Lever 2024 Week 40 This week we report on a UPC Court of Appeal decision that focuses only on costs, and ...
Joanna Smith - October 2, 2024 Mewburn Ellis: top tier firm Legal 500 2025 We are extremely proud to once again be ranked tier one for our patent and trade mark practices in ...
Matthew Naylor - September 30, 2024 UPC Weekly - UPC Court of Appeal digs into the detail in a new preliminary injunction case 2024 Week 39 Outdoor equipment makers Ortovox and Mammut are locked in a UPC battle about avalanche ...
Matthew Naylor - September 23, 2024 UPC Weekly - The first UPC SEP injunction 2024 Week 38 On 13 September 2024, the UPC Munich Local Division handed down its decision in the ...
Joseph Newcombe - September 18, 2024 Professor David Nutt’s new psychedelic mission The expert on drugs is researching the potential to treat mental health disorders with ...
Katherine Green - September 17, 2024 Most opposed companies at the EPO 2023 The European Patent Office grants about 100,000 patents per year (EPO Statistics here). The grant ...
Charlotte Lynch - September 17, 2024 How could NASA tech benefit postmenopausal women? Over 14,000 postmenopausal women in England may benefit from the recent approval of new ...
Matthew Naylor - September 16, 2024 UPC Weekly - Clearing the way can lead to UPC bifurcation and language complexities 2024 Week 37 Let’s say that you are a company based outside Europe and intend to launch a new ...
Fay Allen - September 12, 2024 Dr. Maike de la Roche: immunotherapy & thriving as a woman in science The world-renowned pioneer in immunotherapy tells Mewburn Ellis about her work with CAR-T cells, ...
Frances Salisbury - September 10, 2024 Polycystic Ovary Syndrome awareness month September is PCOS awareness month. PCOS, which stands for Polycystic Ovary Syndrome, is a hormonal ...
Natalie Vaughan - September 9, 2024 BoobyBiome: replicating the breast milk microbiome Breast milk is abundant with essential microbes. Meet the startup mapping the microbiome, to ensure ...
Matthew Naylor - September 9, 2024 UPC Weekly - UPC preliminary injunctions – a top-up 2024 Week 36 Just two weeks ago we reviewed UPC case law on preliminary injunctions (PIs), giving ...
Emily Hayes - September 6, 2024 Preparing your patent for success in EPO opposition proceedings Emily Hayes shares five simple prosecution tips to strengthen EP patents, ensuring they are in the ...
Lucy Coe - September 2, 2024 UPC Weekly - Let’s brake for a minute, and talk about Tesla 2024 Week 35 Last week saw two decisions handed down from the UPC Local Divisions as part of ...
Emma Kennaugh-Gallacher - August 27, 2024 UPC Weekly - UPC Preliminary Injunctions – Background, Trends and Lessons Learned 2024 Week 34 No-one wants to be on the receiving end of a UPC preliminary injunction. The tussles ...
Sarah Harvey - August 23, 2024 The Science of Success: Optimising Female Athletic Performance For the first time in Olympic history, the Paris 2024 Games achieved gender parity among athletes. ...
Amelia Jones - August 21, 2024 Editing in situ: synthetic gene editing tools delivered straight to the gut The critical, yet delicate balance of the microbiome in maintaining health and influencing disease ...
Robert Andrews - August 20, 2024 Antibody-drug conjugates: the new frontier of cancer treatments Antibody-drug conjugates (ADCs) are big business. Big pharma is moving in, snapping up companies or ...
Matthew Naylor - August 19, 2024 UPC Weekly - Revisiting transparency of UPC proceedings 2024 Week 33 The UPC has been doing a lot of stuff right. Litigators praise the preparedness of the ...
Nick Sutcliffe - August 13, 2024 Cellular agriculture – increasing importance of IP in cultivated meat As the cultivated meat industry matures, consolidation is widely anticipated due to increasing ...
Adam Gregory - August 13, 2024 ‘It’s a 50% reduction in ageing’ Singapore startup VVB Bio promises a dramatic reduction in ageing via a single jab. Now out of ...
Sean Jauss - August 12, 2024 UPC Weekly - Now let’s talk about saisies 2024 Week 32 There is no discovery at the UPC.
Louise Atkins - August 9, 2024 Fin-tastic innovation: diving into the future of lab-grown fish Much of the discussion around future food focusses on cultivated meat, with all the products so-far ...
Lauren Woolley - August 6, 2024 Cell-to-cup: a new way to make an old favourite? For those of us who can’t function without our morning coffee, there have been some promising ...
Matthew Naylor - August 5, 2024 UPC Weekly - UPC revocation versus EPO opposition – playing out in not-so-slow-mo 2024 Week 31 What happens when you have the same parties fighting over revocation of the same ...
Richard Clegg - July 31, 2024 New EU sanctions against Russia In late June the EU extended their package of sanctions in view of Russia’s actions in Ukraine by ...
Matthew Naylor - July 29, 2024 UPC Weekly - Where’s your UPC off-ramp? 2024 Week 30 Every litigator needs to have a clear view of the possible routes out of litigation. ...
Thomas Wolter - July 22, 2024 UPC Weekly - UPC Munich Central Division sets out a marker on how the UPC should approach inventive step 2024 Week 29 This week saw the first UPC decision on the merits issued in the long-running patent ...
Louise Atkins - July 17, 2024 Paw-some news for pets: UK’s first regulatory approval of cultivated meat Lab-grown chicken from cultivated meat company Meatly has received regulatory approval in the UK.
Rebecca Tollervey - July 16, 2024 EPO case law for antibodies – 2024 update In 2023 we published a pair of articles reviewing EPO case law in the field of antibodies, ...
Adam Gregory - July 15, 2024 Mewburn Ellis is proud to have worked on 26 of the 100 top-selling pharmaceuticals of 2023 Mewburn Ellis is proud to work with some of the world’s most globally significant pharmaceuticals, ...
Matthew Naylor - July 15, 2024 UPC Weekly - UPC Local Divisions - the reluctant bifurcators 2024 Week 28 This week we look at how the UPC is handling requests to split substantive ...
Matthew Naylor - July 8, 2024 UPC Weekly - UPC overturns EPO opposition division decision on the same prior art 2024 Week 27 In the race to be the first UPC division to produce a written decision on a main ...
Eliot Ward - July 3, 2024 Inside the Asian microbiome library AMILI co-founder Dr Jeremy Lim takes us on a tour of his remarkable lab, where the mysteries of the ...
Matthew Naylor - July 1, 2024 UPC Weekly - Three month delay fatal for a preliminary injunction application 2024 Week 26 On 3 June 2024, the UPC Local Division in Hamburg decided to refuse a preliminary ...
Jane Liu - June 25, 2024 Alive with Possibilities - The Future of Sustainable Plastics and Beyond As the production and consumption of plastics continues to surge, so too has the accumulation of ...
Joseph Newcombe - June 24, 2024 FDA decision on MDMA therapy hangs in the balance Recent positive data from a phase III clinical trial of MDMA assisted psychotherapy for the ...
Matthew Naylor - June 24, 2024 UPC Weekly - UPC uses EPO approach to added subject matter 2024 Week 25 There was lots of UPC news to hold the interest this week but for me the standout was ...
Matthew Naylor - June 17, 2024 UPC Weekly - Opting-out from the UPC: the Who, the When and the Why 2024 Week 24 It seems like a long time ago now, but from March to May 2023, the “sunrise period” of ...
Adam Gregory - June 17, 2024 Podcast with Adam Gregory: protecting innovations in the biotech space Adam Gregory joins John Joson Ng on Nucleate Singapore’s Pulse podcast where he highlights success ...
Eliot Ward - June 14, 2024 How helpful are biological deposits at the EPO? In our article about biological deposits under the Budapest Treaty, we explored the deadlines and ...
Matthew Naylor - June 10, 2024 UPC Weekly - Three Known Unknowns at the UPC 2024 Week 23 It’s a bit risky to write a blog where you hope it will go out of date quickly. But ...
Charlotte Lynch - June 4, 2024 The HPV vaccine: the global success of prioritising women’s health Let's talk about the HPV vaccine - a revolutionary drug and global strategy that proved how ...
Sean Jauss - June 3, 2024 1st Anniversary of the UPC – some stats! The Unified Patent Court (UPC) celebrated its first anniversary on 1 June 2024. The Court is busy. ...
Matthew Naylor - June 3, 2024 UPC Weekly - Should we stay or should we go on? 2024 Week 22 This week we report on the UPC revocation action in Bitzer v. Carrier and the related ...
Matthew Naylor - May 28, 2024 UPC Weekly - Let’s talk about costs 2024 Week 21 This week we focus how the UPC is dealing with requests for security for costs and the ...
Matthew Naylor - May 20, 2024 UPC Weekly - UPC Court of Appeal confirms their own case law on claim interpretation but sidesteps question of file wrapper estoppel 2024 Week 20 The UPC Court of Appeal have issued another decision on a preliminary injunction – ...
Matthew Naylor - May 13, 2024 UPC Weekly - High bar to challenge the jurisdiction of the UPC 2024 Week 19 This week saw the UPC issue two decisions about its own jurisdiction. Where a ...
Amelia Jones - May 13, 2024 Bacteria bites back: Putting carbon on the menu When faced with solving the climate crisis, no idea is too ambitious for Synthetic Biology (SynBio) ...
Matthew Naylor - May 7, 2024 UPC Weekly - Preliminary injunctions at the UPC – get your defence ready 2024 Week 18 This week we look at a recent UPC first instance decision for a preliminary ...
Joanna Smith - May 1, 2024 Our clients are at the heart of our Trade Mark business We are delighted to release our latest brochure 'Our clients are at the heart of our Trade Mark ...
Matthew Naylor - April 29, 2024 UPC Weekly - Battling the Biosimilars: opt-outs, preliminary injunctions & protective letters 2024 Week 17 This week we delve into the details of the first two UPC disputes involving ...
Eleanor Maciver - April 26, 2024 Cleantech Commercialisation Report: Highlights and Trends Today (26 April 2024) the European Patent Office (EPO) and the European Investment Bank (EIB) ...
Camille Terfve - April 26, 2024 The brilliant dawn of AI drug discovery Computer simulations are solving challenges previously thought uncrackable.
Andrew Mears - April 26, 2024 Medical devices: Insights through IP - new report 2024 We are delighted to release our latest report Medical devices: Insights through IP which looks at ...
Matthew Naylor - April 22, 2024 UPC Weekly - Language of proceedings at the UPC 2024 Week 16 This week we focus on the language of proceedings at the UPC, considering when the ...
Matthew Naylor - April 15, 2024 UPC Weekly - Time-dependent transparency of UPC proceedings? 2024 Week 15 The week saw the Court of Appeal issue its decision on public access to court file ...
Matthew Naylor - April 10, 2024 UPC Weekly - Mind your costs 2024 Week 14 The UPC Court of Appeal issued a collection of five appeal decisions on 3 April 2024 ...
Matthew Naylor - April 3, 2024 Public access to UPC proceedings When the UPC was set up, a basic tenet was set out in Article 45 of the UPC Agreement, that the ...
Katherine Collins - April 2, 2024 Efficiency in Expansion: Meeting the Scale-Up Challenge in Cell and Gene Therapies One of the pivotal challenges in the development and commercialisation of cell and gene therapies ...
Fay Allen - March 27, 2024 Endometriosis - research, diagnosis and treatment progress March is Endometriosis Action Month, and this year’s focus is on raising awareness.
Edward Couchman - March 25, 2024 Cancer-killing bacteria: past, present and future While bacteria have frequently made the medical news in recent years due to the urgent problem of ...
Lucy Coe - March 11, 2024 Challenging patents and other clearance actions in Europe Whether it is to remove a current infringement threat, clear the way to reduce the risk in ...
Nick Sutcliffe - March 4, 2024 Cellular Agriculture – Innovating through the Challenges The last year (2023) has seen a difficult environment for Cellular Agriculture (Cell Ag) companies ...
Eliot Ward - February 29, 2024 The link between the microbiome and chronic liver disorders Guts UK is the charity for the digestive system. It funds scientific research such as Nicholas ...
Rebecca Brooks - February 29, 2024 Updates to the Guidelines for Examination at the EPO The Guidelines for Examination at the EPO (which will be referred to as “the Guidelines” in this ...
Katie Dale - February 26, 2024 Top marks for Iovance as FDA approves first-in-class cell therapy Amtagvi for solid tumours On February 16, 2024, a real milestone was reached in the cell therapy field, as the FDA approved ...
Isobel Fisher - February 22, 2024 Colony picking robot expands our knowledge of human gut microbiome The human microbiome is very diverse. A typical gut microbiome can contain hundreds or even ...
Rebecca Tollervey - February 22, 2024 Antibody inventions: Updates in the EPO Guidelines for Examination The EPO Guidelines for Examination are set to undergo updates effective from 1 March 2024. The ...
Eliot Ward - February 21, 2024 Biological Deposits under the Budapest Treaty (1977): important considerations for filing strategies and public accessibility Biological material, which the EPO understands to be any material containing genetic information ...
Amelia Jones - February 13, 2024 Blooming bright! Bioluminescent plant set to brighten up flower beds across the US The green fingered among us take great pride in our blossoming gardens and house plants; those, ...
Frances Salisbury - February 8, 2024 Yoni Health: the medical secrets of menstrual blood Menstrual effluent contains a wealth of scientific info, including biomarkers for endometriosis, ...
Sarah Harvey - February 8, 2024 European Parliament votes to endorse plants bred using New Genomic Techniques 7 February 2024 marked a milestone for plant science as the European Parliament (EP) voted to ...
Edward Couchman - February 7, 2024 Genes as Medicines: Treating the Untreatable In 2023, gene therapy hit the headlines in the UK, when the BBC reported the cure of a toddler with ...
Amelia Jones - February 7, 2024 Fertile Ground: Tapping into the Potential of the Female Microbiome Healthcare systems around the world have historically been designed by men, with “white males” ...
Katherine Green - February 2, 2024 Most opposed patents of 2023 Multiple sclerosis therapies are the subject of two of the most opposed patents of 2023. Novartis’ ...
Sarah Harvey - January 31, 2024 Hydrogels in sustainable agriculture As we move into 2024, the agricultural sector is being driven by the urgent need to address global ...
Emily Lythell - January 26, 2024 Gouda vibes only – AI cooks up vegan meat and cheese alternatives The Kraft Heinz Company has recently introduced three new vegan sliced cheese varieties in the ...
Rebecca Brooks - January 22, 2024 One Health and the role of the microbiome Traditionally, clinical microbiology focused on the role of individual microbes in human and animal ...
Lauren Woolley - January 11, 2024 Eat your greens: innovations in sustainable alternative protein sources As the demand for plant-based products continues to grow, so too does the rate of advancement in ...
Emily Lythell - January 5, 2024 Antibiotic with novel mechanism offers new hope for treating resistant infections This week saw the publication of a potential new class of antibiotics and their mechanism ...
Robert Andrews - January 4, 2024 Podcast with Robert Andrews: a forward-thinking approach to inclusion & diversity Robert Andrews joins Lisa Mueller and Vivian Luiz Coco on their Inclusion Evolution podcast to ...
Lauren Woolley - January 3, 2024 Mewburn Ellis is proud to be participating in Veganuary (again) Following last years’ success, we will once again be taking part in the Veganuary Workplace ...
Simon Kiddle - January 2, 2024 The wonderful potential of waxworm saliva Enzymes are able to break up plastic, opening the way for rapid recycling.
Joseph Newcombe - December 19, 2023 The Royal Institution's new mission With 1.4 million subscribers on YouTube, the organisation is finding new ways to enthuse the ...
Amelia Jones - December 19, 2023 Synthetic probiotics: bacteria that link the gut to the brain Optimising pharmacokinetics of a drug is a vital stage of the development process. Pharmacokinetics ...
Eleanor Maciver - December 18, 2023 Saved by the cell: taking the animals out of meat Entrepreneur Joshua Errett is aiming to remove animals from the food chain. His first move is to ...
Calum Graham - December 14, 2023 National Vision for Engineering Biology On Tuesday 5 December 2023, the Minister for Science, Research and Innovation, Andrew Griffith MP, ...
Joseph Newcombe - December 12, 2023 New highs for psychedelics in the clinic Psychedelic compounds have long been experimented with for their mind-altering properties, but in ...
Amelia Jones - December 4, 2023 Enzyme-based carbon capture: as easy as breathing Over the past few years, the impact of the climate crisis has never been far from the front pages. ...
Niles Beadman - November 28, 2023 Invention Capture: 5 Steps to Success - Transforming Technology to Patent Protection Invention capturing, also referred to as invention harvesting or invention mining, is the start of ...
Alex Galbraith - November 17, 2023 The first CRISPR treatment – Casgevy wins UK approval for sickle cell disease In a world first, the UK medicines regulator has given the green light to a therapy employing ...
Isobel Fisher - November 17, 2023 Biosensor bacteria for tumor detection Genetically engineered biosensor bacteria could allow us to detect colon cancer without the need ...
Katherine Green - November 13, 2023 Most opposed patents of 2022 As with CRISPR, patents directed to Nobel Prize-winning technologies are viewed as extremely ...
Jacqueline Murphy - November 8, 2023 Validating European patents outside Europe - the Validation State system We are pleased to launch our latest report Validating European patents outside Europe - the ...
Katie Dale - November 6, 2023 Swapping in stem cells for diabetes treatment With just under 50% of type 1 diabetes patients using wearable blood glucose monitors1, medical ...
Joanna Smith - October 19, 2023 Chambers & Partners 2024 legal guide - Band 1 We are proud to have once again been ranked Band 1 (gold) in Chambers & Partners 2024 legal ...
Rebecca Brooks - October 6, 2023 Supporting Guts UK and their research into the gut microbiome We’re pleased to announce that we have started a new charity partnership with Guts UK. Guts UK was ...
Joanna Smith - October 5, 2023 Mewburn Ellis: top tier firm Legal 500 2024 We are extremely proud to once again be ranked tier one for our patent and trade mark practices in ...
Eliot Ward - October 4, 2023 UPC at four months old - a review The UPC is now four months old and the Court of First Instance is already quite busy. As of 4 ...
Joanna Smith - October 4, 2023 Congratulations to our Rising Stars 2023 Congratulations to Eleanor Maciver, Anna Mudge and Ben Tolley for being recognised as Rising Stars ...
Nick Sutcliffe - October 3, 2023 Covid autumn booster vaccine 2023: the switch to mono-valent vaccines Autumn 2023 sees another round of COVID-19 booster jabs across the UK for vulnerable people.
Sean Jauss - September 29, 2023 Beware the front-loaded procedure! The Unified Patent Court (‘UPC’) opened its doors on 1 June 2023. It is a new court in the European ...
Sarah Harvey - September 21, 2023 UK regulators decide preferred approach to precision bred crops Yesterday (Wednesday 20 September 2023), the Food Standards Agency board decided on their preferred ...
Amelia Jones - September 5, 2023 A leap forward in slowing down Alzheimer’s This summer has seen a major leap forward in slowing the rate of progression of Alzheimer’s disease.
Alex Galbraith - September 1, 2023 Gene therapy – the status quo and future trends The uptick in recent approvals in the gene therapy space is emblematic of a field which is now ...
Adam Gregory - August 11, 2023 VC tips for SMEs — how do VCs evaluate the value of intellectual property? As part of a series in which we ask leading venture capitalists to answer a question of fundamental ...
Tom Furnival - August 10, 2023 UPC as a forum for SEP disputes – Panasonic kick off proceedings With the UPC opening its doors just over two months’ ago, the IP profession has been keenly ...
Fay Allen - August 10, 2023 In vivo expression of chimeric antigen receptors: using gene therapy to improve cell therapy In vivo CAR therapies build on the success of standard CAR treatments and aim to overcome the ...
Anna Mudge - August 9, 2023 The next-generation therapies for autoimmune diseases The immune system has an extraordinary capacity to distinguish “self” from “non-self”. This means ...
Edward Couchman - August 7, 2023 Cells as medicines: the promise of cell therapy Cell therapy is one of the most exciting areas of medical science, with recent years having seen ...
Nick Sutcliffe - July 26, 2023 IP priorities for forward-looking cell and gene therapy businesses IP priorities are especially important to businesses developing advanced therapeutic products. ...
David Brooks - July 19, 2023 Mewburn Ellis is proud to work on 18 of the 50 top-selling pharmaceuticals of 2022 Last year we reported the unprecedented growth of the innovative pharmaceuticals industry in 2021 ...
Jacqueline Murphy - July 18, 2023 Does Green IP mean go? Exploring acceleration under the UKIPO’s “Green Channel” We are pleased to launch our latest report Does Green IP mean go? Exploring acceleration under the ...
Eliot Ward - July 14, 2023 The secrets of the oral microbiome More than 700 species of bacteria live in our mouths. The mysteries of this ecosystem are now being ...
Thomas Driver - July 13, 2023 Evolution of engineered minimal cells - high mutation rates and regained fitness Engineered bacterial cells with minimal genomes were developed in 2016 - these minimal cells ...
Nick Sutcliffe - July 6, 2023 VC tips for SMEs — how much equity should a start-up give away in a Series A fundraising? As part of a series in which we ask leading venture capitalists to answer a question of fundamental ...
Nick Sutcliffe - July 6, 2023 VC tips for SMEs — how to choose the right VC? As part of a series in which we ask leading venture capitalists to answer a question of fundamental ...
Thomas Wolter - July 6, 2023 Beating the Punch: UPC Protective Letters The Unified Patent Court (UPC) is now operational. As of June 1, 2023, patentees can enforce ...
Sean Jauss - July 5, 2023 Litigation in the Unified Patent Court (UPC) The UPC is a new European patent litigation court. It will provide a single forum for the ...
Sean Jauss - June 27, 2023 UPC Administrative Committee approves Milan as host of the third Central Division court The UPC Administrative Committee has announced that Milan will host the third seat of the UPC’s ...
Adam Gregory - June 22, 2023 Cell-cultivated chicken approved for sale in US On Wednesday 21 June 2023, the United States Department of Agriculture (USDA) approved the sale of ...
Isobel Fisher - June 22, 2023 One giant leap for plant-kind: engineering plants for Mars If humans are going to live on Mars one day, we need to work out how to grow plants there. Plants ...
Robert Andrews - May 22, 2023 Podcast with Robert Andrews: how to drive I&D progress and engage key stakeholders Robert Andrews joins Natasha Rainey on her All Inclusive Podcast to discuss his journey to becoming ...
Rebecca Tollervey - May 9, 2023 Patenting antibodies – the latest developments from the EPO Boards of Appeal: Part 2 – inventive step We have conducted a review of Board of Appeal decisions relating to antibody patents published ...
Alex Burns - May 5, 2023 Gene sequencing accelerates with custom hardware The cost to sequence a genome continues to drop exponentially. Over the past 20 years, the cost to ...
Eliot Ward - May 4, 2023 The ball is rolling at the FDA for microbiome therapies The FDA was busy last week! Off the back of the first approval for faecal microbiota transplant ...
Anna Mudge - May 4, 2023 The allogeneic advantage Bespoke cell therapies are expensive and time-consuming. Now allogeneic cell treatments offer a ...
Anna Mudge - March 21, 2023 Advanced Therapies Congress 2023 - five key themes Anna Mudge enjoyed a bustling two days at the Advanced Therapies Congress 2023 in London. Nine ...
Jacqueline Murphy - March 14, 2023 Femtech: a growth industry - new special report We are delighted to release our latest report Femtech: a growth industry.
Jacqueline Murphy - March 7, 2023 Come and join us for a ‘Celebration of all things Singapore’ We are excited to be in Singapore for INTA 2023 and very much hope that you can join us at our ...
Chris Denison - March 6, 2023 Cheese without cows How Better Dairy are creating products that are molecularly identical to traditional dairy (without ...
Matthew Barton - March 3, 2023 Conservation innovation – working towards a world for both humans and wildlife With a rapidly growing human global population, predicted to reach 10 billion by 2057, our impact ...
Natalie Vaughan - February 23, 2023 Microbiome claims around the world: how to define your microbe? A booming commercial interest in harnessing the human microbiome for therapeutic uses has led to a ...
Anna Mudge - February 20, 2023 Trafficking T cells – how to get cells to their target destination After being in the shadow of its famous relative, the antibody-producing B cell, for many decades, ...
Christopher Casley - February 9, 2023 AI and Tech innovation stands out in a slow year for pharma deals Last year saw a drop in the number and value of deals performed in the biotech and pharma sector ...
Lauren Woolley - February 3, 2023 Veganuary: what a month it has been! Veganuary is done for another year. What a month it has been!
Sarah Harvey - February 3, 2023 Veganuary: what we eat - 5 tips for sustainability As Veganuary comes to a close, we are preparing to return to our normal lives and, indeed, diets. ...
Callum Anderson - February 3, 2023 Getting to grips with device led physical rehabilitation innovation In the UK, there are an estimated 187,000 children living with an arm disability, and 85 million ...
Emma Graham - February 2, 2023 Meet the team: Emma Graham, Partner and Patent Attorney in the Engineering team, London As part of our 'meet the team' series, we talk to Emma Graham about her love of patent drafting, ...
Rebecca Tollervey - February 1, 2023 Patenting antibodies – the latest developments from the EPO Boards of Appeal The prosecution of patent applications relating to antibodies involves particular considerations. ...
Camille Terfve - January 31, 2023 Meet the team: Camille Terfve, Partner and Patent Attorney in the Life Sciences team, Cambridge As part of our 'meet the team' series, we talk to Camille Terfve about her journey to becoming a ...
Lauren Woolley - January 23, 2023 Veganuary: food for thought - ethical considerations when navigating the future food technology landscape Our focus this Veganuary has been on the technology leading the way in this sector, and in ...
Katie Dale - January 21, 2023 CAR Treg cell therapy - to autoimmunity and beyond A new wave of cell therapy is hitting the clinics for treating various autoimmune diseases, by ...
Christopher Casley - January 20, 2023 Meet the team: Christopher Casley, Partner and Patent Attorney in the Life Sciences team, Bristol As part of our 'meet the team' series, we talk to Christopher Casley about why he enjoys life as a ...
Amelia Jones - January 20, 2023 Synthetic Biology - creating innovative solutions to tackle climate change Over the past few decades, awareness of the impact that humans are having on the planet has grown ...
Rebecca Anderson-Smith - January 19, 2023 Veganuary: vegan branding – more than meats the eye The Veganuary challenge is in full swing, at Mewburn Ellis, and across the UK more generally. But ...
Richard Clegg - January 18, 2023 Opting out from the UPC – when to opt-out a pending European patent application From 1 March 2023, when the Unified Patent Court (UPC) sunrise period starts, it will become ...
Lauren Woolley - January 17, 2023 Veganuary: horizons in next-generation plant-based meat analogues Here at Mewburn Ellis, we have been thinking about the future of food for some time. Since 2019, we ...
Louise Atkins - January 10, 2023 Veganuary: Culturing an appetite; advances in 3D bioprinting Throughout Veganuary, we are looking at the technologies that are taking us beyond animal ...
Lauren Woolley - January 4, 2023 Mewburn Ellis is proud to be participating in Veganuary At Mewburn Ellis, we have been thinking about the future of food for some time. So have the ...
Katherine Collins - December 23, 2022 A world-first approval for off-the-shelf cell therapy We are delighted to learn that this week the European Commission granted the world’s first approval ...
Nick Sutcliffe - December 20, 2022 mRNA cancer vaccine shows efficacy in clinical trial Moderna and Merck announced in a mid-December 2022 press release that its mRNA cancer vaccine ...
Chris Denison - December 16, 2022 Podcast with Jevan Nagarajah: Cheese without cows Jevan Nagarajah, Co-Founder and CEO of Better Dairy, joins Forward Editor Charles Orton-Jones to ...
Eliot Ward - December 1, 2022 Welcome to the market, FMT On Wednesday 30 November 2022, the U.S. Food and Drug Administration (FDA) authorised the first ...
Thomas Driver - December 1, 2022 What is Synthetic Biology and why should you care? The term Synthetic Biology, or SynBio, has been used for a while; the meaning of the term seems to ...
Alex Galbraith - December 1, 2022 Antibody therapy for pets – following the human lead Over recent decades monoclonal antibody (mAb) therapy has developed from a standing start to become ...
Jacqueline Murphy - November 29, 2022 Patent Litigation Trends in England & Wales - new report We are delighted to release our latest report Patent Litigation Trends in England and Wales.
Thomas Wolter - November 21, 2022 Plausibility and Inventive Step at the EPO - Watch G2/21 live on Thursday 24 November On Thursday 24 November 2022, the Enlarged Board of Appeal (EBA) will hear the parties in case ...
Adam Gregory - November 18, 2022 Coming soon to a plate near you? US Food and Drug Administration issue first step towards approval for cell-based meat For over a decade, the promise of cultivated meat, grown using cell-culture techniques ex vivo and ...
Julie Carlisle - November 16, 2022 European validation strategies for pharmaceutical patents – an update In January 2021, we published our Special Report on EP validation strategies for pharmaceutical ...
Simon Kiddle - November 16, 2022 Positive feedback on oral proceedings in oppositions carried out by videoconference In September, the EPO commissioned a survey about their opposition procedure, in particular asking ...
Edward Couchman - November 11, 2022 Enablement Requirements for Antibody Claims to be Reviewed by US Supreme Court In a development which will be of interest to biotech companies, particularly those working in the ...
Frances Salisbury - November 9, 2022 Gender bias in patent prosecution Fran Salisbury spoke to The Patent Lawyer Magazine about gender bias in patent prosecution. This ...
Katherine Green - November 7, 2022 Eight days – the longest ever opposition hearing at the EPO? The EPO Opposition Division just issued its decision on European Patent 2 188 302 following an ...
Matthew Barton - November 1, 2022 Vets: who’s taking care of the animal caregivers? Our pets are members of the family, and we would do everything we can to make sure they stay fit ...
Jacqueline Murphy - October 25, 2022 Top Tier in Chambers & Partners 2023 legal guide We are proud to have once again been ranked Band 1 (gold) in Chambers & Partners 2023 legal ...
Jacqueline Murphy - October 14, 2022 Mewburn Ellis: top tier firm Legal 500 2023 We are extremely proud to be ranked tier one for our patent and trade mark practices in the 2023 ...
Maria Hall - October 14, 2022 Robert Watson elected President of FICPI’s Study and Work Committee Partner Robert Watson was elected President of FICPI’s Study and Work Committee (Commission d'Etude ...
Jacqueline Murphy - October 5, 2022 Congratulations to our Rising Stars 2022 Congratulations to Eleanor Maciver, Anna Mudge and Ben Tolley for being recognised as Rising Stars ...
Andrew Pitts - October 4, 2022 A patent attorney, a dog and meaning in the job 4 October 2022 is World Animal Day and we can reflect on how the strong bond with our canine ...
Eliot Ward - September 12, 2022 Regulatory challenges for microbiome therapeutics in the EU and beyond – focus on FMT One of the oldest known microbiome-based therapeutics, faecal microbiota transplantation, is again ...
Emily Hayes - August 5, 2022 We perform significantly better than the EPO average at oppositions We really are experts when it comes to opposing patents and our enviable success rate speaks for ...
Eleanor Maciver - August 3, 2022 Alternative proteins: you can’t magic anything out of thin air – or can you? It’s hard to miss the scale of investor and consumer appetite for sustainable, future foods. Future ...
Katie Dale - July 28, 2022 Bugs helping drugs beat cancer – harnessing the microbiome for immunotherapy In recent years the field of cancer immunotherapy has exploded in popularity, and now a new branch ...
Katherine Green - July 28, 2022 Most opposed patents of 2021 When we reviewed our list of the most opposed European patents of 2021, we found that the patent at ...
Adam Gregory - July 22, 2022 Mewburn Ellis is proud to work on 19 of the 50 top-selling pharmaceuticals of 2021 2021 was a year of unprecedented success for the biotech and pharmaceutical industries, with the ...
Eliot Ward - July 7, 2022 Breakthrough: super fast DNA tests A rapid bedside genetic test can screen newborn babies for a genetic variant which makes them ...
Thomas Wolter - June 27, 2022 EPO presses pause on proceedings that depend on the plausibility referral to the EBA Despite not having any express legislative basis in the European Patent Convention, plausibility ...
Julie Carlisle - June 22, 2022 The surprising world of canine oncology Dog cancer specialist Dr Clare Knottenbelt reveals the insights derived from studying and treating ...
Rebecca Anderson-Smith - May 26, 2022 Plant-based brands: what does it take to break through? We investigate what it takes to stand out in an increasingly crowded retail space.
Anna Mudge - May 24, 2022 Recipe for success - intellectual property opportunities in future food The future of food is big business and it’s only going to get bigger as both technology and ...
Sarah Harvey - May 10, 2022 Vertical farming - finding space to sprout up One thing the past couple of years have taught a lot of people is that global supply chains can be ...
Sarah Harvey - May 6, 2022 Replacing the bad with the good – an IP perspective on microbial consortia Our body hosts trillions of microorganisms that are essential to many aspects of human health. This ...
Rhiannon Wescott - May 3, 2022 The search for more sustainable food sources So much more than nutrition, food can evoke pleasure and excitement and bring people together. And ...
Thomas Wolter - April 27, 2022 Plausibility strikes again – BMS blockbuster apixaban patent found invalid by UK High Court In a recent judgment the UK High Court of Justice revoked European Patent (UK) 1 427 415 B1 and a ...
Tanis Keirstead - April 14, 2022 Horizons in vaccine production The scramble for a coronavirus vaccine over the last two years has demonstrated how important ...
Urs Ferber - April 14, 2022 Germany’s world-leading MedTech industry Germany is synonymous with precision engineering and quality manufacturing, so it comes as no ...
Tanis Keirstead - April 4, 2022 A much-needed boost: the future of coronavirus vaccines Just over two years after our first blog on Covid-19, it appears that the disease is here to stay. ...
Isobel Stone - April 4, 2022 Powering pacemakers – (don’t) be still, my beating heart Millions of people around the world depend on implanted medical devices, for all sorts of reasons – ...
Adam Gregory - March 31, 2022 Podcast with Guy Heathers: Singapore's innovation community — trends and technology Having previously spoken to Guy Heathers, Singapore biotech entrepreneur, about the development of ...
Adam Gregory - March 30, 2022 Five patenting pitfalls in future food (and how to avoid them) In our series on future food, we have explored the exciting innovations in areas such as cultured ...
Katie Dale - March 14, 2022 Exosomes in liquid biopsy: a nanometric particle packed with potential We are all too familiar with the statistic that 1 in 2 of us will get cancer in our lifetime. Of ...
Fay Allen - March 8, 2022 We need to talk about women's health - spotlight on endometriosis Women’s health is an area that has suffered from gender bias for years. One reason for this is that ...
Robert Worboys - March 7, 2022 Six ways that 3D printing is revolutionising the biomedical industry 3D-Printing is an additive manufacturing process whereby objects are created by depositing ...
Frances Salisbury - February 10, 2022 Predicting the unpredictable during pregnancy For many expectant parents, pregnancy is a time of excitement, yet this time can also be riddled ...
Katherine Green - January 26, 2022 A guide to EPO opposition proceedings by videoconference EPO oppositions by videoconference only became possible relatively recently, in April 2020. In 2021 ...
Chris Denison - January 20, 2022 Kokumi - a new taste for future foods? Many of us – at least in the West – grew up with the knowledge that there are four basic tastes: ...
Eliot Ward - January 19, 2022 As the UPC preparatory period begins, the EPO decides to accept UP requests before the full UPC agreement comes into force On 18 January 2022, Austria became the thirteenth EU country to ratify the “protocol on ...
Eliot Ward - December 3, 2021 Austrian parliament unanimously passes legislation to allow the practical preparations for the UPC to begin On 2 December 2021, Austria became the thirteenth EU country to pass the “protocol on provisional ...
Alex Burns - November 22, 2021 The smart healthcare revolution – what does it mean for patent attorneys? In 2020 the EPO published a report on the global trends in patent applications for “Fourth ...
Camille Terfve - November 16, 2021 From academia to patents – a career path to becoming a patent attorney Camille Terfve spoke to EMBL Careers about what it takes to become a patent attorney. This was ...
Camille Terfve - November 12, 2021 Digital therapeutics: the rise of digital health technologies during the Covid-19 pandemic There is no denying that the Covid-19 pandemic has reshaped many aspects of our lives. Those lucky ...
Jacqueline Murphy - October 26, 2021 New Green IP Report launched To coincide with the launch of COP26 we have released a new report into Green IP. Our report ...
Jacqueline Murphy - October 22, 2021 Chambers & Partners 2022 Legal Guide - Band 1 Recommended Firm We are delighted to have once again been ranked Band 1 in Chambers & Partners 2022 legal guide ...
Christopher Casley - October 21, 2021 A snapshot: Patent Landscape in Bioinformatics and Digital Health In this Forward: On Demand vlog, Christopher Casley gives us an overview of our special report on ...
Jane Liu - October 21, 2021 Capturing the DNA hydroxymethylome for early-stage cancer detection Biomarkers are measurable indicators of health or disease and the detection of biomarkers in liquid ...
Joseph Morgan - October 14, 2021 CRISPR - the future of gene editing In this Forward: On Demand vlog, Joseph Morgan and Alex Galbraith explore what CRISPR/Cas9 is, how ...
Andrew Williams - October 5, 2021 Change and Opportunity: SPCs in the post-Brexit era Supplementary Protection Certificates (SPCs) are incredibly important IP rights that help ...
Jacqueline Murphy - October 4, 2021 MIP IP Stars - The Rising Stars in IP 2021 Congratulations to Rebecca Anderson-Smith, Callum McGuinn and Ben Tolley for being recognised as ...
Isobel Stone - October 1, 2021 ‘IP Access’ fund, an extension of the existing UK IPO IP Audits Plus program In 2021, innovation really has been a hot topic, with the government’s Innovation Strategy ...
Jacqueline Murphy - September 30, 2021 Mewburn Ellis: top tier firm Legal 500 2022 Mewburn Ellis is proud to be ranked top tier for our patent and trade mark practices in the 2022 ...
Andrew Mears - September 21, 2021 Sensors and sensibility: Caroline Hargrove CBE eyes up the future of healthtech Years after meeting her as another primary-school parent, Forward editor Caitlin Mackesy Davies ...
Adam Gregory - September 17, 2021 Three ways future food technologies can improve the sustainability of animal feed Like many others, lockdown has changed not only the daily rhythm in my home but the members of the ...
Adam Gregory - September 9, 2021 IP priorities for future food companies The future of food is a hot topic. Whether it is cellular agriculture, next-generation meat ...
Rebecca Tollervey - September 8, 2021 The other end of the antibody: Fc modifications as a focus for patent protection For us antibody nerds, a fascinating aspect of the development of monoclonal antibodies against ...
Samuel Hart - September 8, 2021 Liquid biopsies and the future of cancer treatment In this Forward: On Demand vlog, Samuel Hart discusses liquid biopsy technologies and the future of ...
Katherine Green - September 6, 2021 Most opposed patents of 2020 Every year at the EPO about 3000-4000 patents are opposed. This figure represents only about 3-4% ...
Andrew Pitts - August 10, 2021 A new referral to the EPO’s Enlarged Board of Appeal is plausible Despite not having any express legislative basis in the European Patent Convention, plausibility ...
Camille Terfve - August 5, 2021 Patent Landscape in Bioinformatics and Digital Health Special Report Our new Special Report, Patent Landscape in Bioinformatics and Digital Health: a data driven ...
Daniel Yin - July 28, 2021 Senolytics are knock, knock, knocking on ageing’s door In 1974, Bob Dylan asked that we stay forever young. Today, exciting developments in the longevity ...
Fay Allen - July 28, 2021 Is metformin the key to anti-aging? By 2050, it is estimated that one quarter of the global population will be over 60 years old. That ...
Joseph Morgan - July 19, 2021 First human in vivo CRISPR/Cas9 gene editing results make history The ability to directly edit a patient’s genome safely and efficiently to treat genetic diseases ...
Jacqueline Murphy - July 2, 2021 IAM Patent 1000: The World’s Leading Patent Professionals 2021 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Samuel Hart - June 30, 2021 Circulating tumour cells: at the forefront of cancer diagnosis and treatment In cancer patients, “metastasis” occurs as tumour cells break-away from the site at which they are ...
Thomas Driver - June 30, 2021 Cancer diagnosis – new data to support methylation-based liquid biopsy New study demonstrates enormous potential Earlier this month, we published a blog which highlighted ...
Adam Gregory - June 29, 2021 Podcast with Jim Mellon: Cellular agriculture and the new agrarian revolution Jim Mellon, investor in innovation, entrepreneur and author, joins us for our new podcast. With ...
Fay Allen - June 29, 2021 The technologies helping shape the future of food In this Forward: On Demand vlog, Fay Allen and Sarah Harvey discuss the technologies helping shape ...
Jacqueline Murphy - June 23, 2021 Pharma and Life Sciences Patent Extensions in Europe Our Special Report Pharma and Life Sciences Patent Extensions in Europe examines five years of data ...
Sarah Kostiuk-Smith - June 21, 2021 Podcast with Sarah Kostiuk-Smith: Validation strategies for pharmaceutical patents in Europe Sarah Kostiuk-Smith, Partner and Patent Attorney at Mewburn Ellis (UPDATE 30 SEPTEMBER 2022: Sarah ...
Jacqueline Murphy - June 17, 2021 Mewburn Ellis ranked Tier 1 for Patent prosecution in MIP IP STARS 2021 We are delighted to be ranked Tier 1 for Patent Prosecution UK in MIP IP STARS 2021. As one of only ...
Finn Dinneen - June 17, 2021 Financial Times Special Report - Europe's Leading Patent Law Firms 2021 We are delighted to once again be recognised in the Financial Times Special Report Europe’s Leading ...
Edward Couchman - June 15, 2021 Cell therapy: repairing and rebuilding the body Recent advances in medicine have, for the first time, allowed physicians to directly intervene in ...
Thomas Driver - June 9, 2021 Methylomics – analysing DNA methylation signatures to diagnose cancer Traditional tissue biopsies are a vital aspect of current medical practices which help us diagnose ...
Jo Cripps - June 8, 2021 Need to Know: why your virome holds enormous value Our bodies play host to a complex network of viruses, many of which remain unclassified. Matt ...
Samuel Hart - June 3, 2021 Healthy eating means more than just a balanced diet: future foods and fighting the risk of infection Human health is inextricably linked to food – not least because eating a healthy diet is known to ...
Camille Terfve - May 20, 2021 Intellectual property and artificial intelligence in the UK: what might the future hold? AI is a hot topic for the current UK government. Last year, the UK Intellectual Property Office ...
Nick Sutcliffe - May 14, 2021 IP for forward-looking life sciences businesses The recently released Mewburn Ellis IP Guide for SMEs sets out IP priorities for businesses at four ...
Alex Galbraith - May 12, 2021 Diagnosing concussion: liquid biopsy is changing the game Rugby, along with many other contact sports such as football, boxing and American football, has ...
Jacqueline Pang - April 23, 2021 What's the beef? Using meat terms to describe meat alternatives With the ‘future foods’ market set to grow exponentially over the coming years as a result of a ...
Fay Allen - April 19, 2021 What is the cancer microbiome? The “microbiome” is commonly associated with the gut microbiome, but recently the blood microbiome ...
Adam Gregory - April 19, 2021 Fish-free-fish: making a splash with cellular aquaculture Whilst the oceans remain as vast and seemingly inexhaustible as ever, the old adage that “there’s ...
Adam Gregory - April 19, 2021 Jim Mellon: the reluctant gradualist taking on ageing Forward editor Caitlin Mackesy Davies learns how we might all be able to live long and prosper from ...
Isobel Stone - April 7, 2021 Need to know: are we set for a bioprinting boom? From refashioning foods to fabricating organs, bioprinting is the smart technology that could have ...
Lucy White - March 31, 2021 The future of organ transplantation: growing organs from scratch? Organ transplantation has saved, transformed, and extended countless lives. Although ...
Sarah Harvey - March 23, 2021 EPO 2020 Patent Index - key trends The European Patent Office (EPO) recently published its 2020 Patent Index which provides a ...
Alex Galbraith - March 8, 2021 Detecting progress: liquid biopsy in lung cancer Lung cancer remained the leading cause of cancer death in 2020 with an estimated 1.8 million deaths ...
Chris Denison - March 5, 2021 Webinar - Antibody patenting practice at the EPO A new edition of the EPO Examination Guidelines came into force on 1 March 2021, including a new ...
Simon Kremer - March 3, 2021 Controlled environment agriculture - 5 things to watch Simon Kremer attended the Agri-TechE “Controlled Environment Agriculture – The Industry is Growing ...
Rebecca Tollervey - March 2, 2021 Patenting highly engineered antibodies in Europe In recent years, antibody engineering has moved into a new phase of complexity, with a ...
Chris Denison - February 10, 2021 New EPO Guidelines for Examination of Antibody Inventions A new edition of the EPO examination guidelines will come into force on 1 March 2021. The EPO has ...
Robert Watson - February 5, 2021 Out of Oz: the remarkable life and times of AMP945 Bringing a new cancer treatment to the public can be a complex process, as Alex Eliseev finds out.
Adam Gregory - January 29, 2021 SARS-CoV-2 variants – reasons to be optimistic In recent weeks and months, several highly-transmissible variants of SARS-CoV-2 (the virus that ...
Adam Gregory - January 29, 2021 Conscious consumers deserve better than burgers As part of our Thought Leaders series, Director and Co-founder of Gaia Foods, Vinayaka Srinivas, ...
Alex Burns - January 26, 2021 How to patent your digital health apps – 5 key considerations As the technical capabilities of smartphones continue to rise at an exponential rate, so too do the ...
Thomas Driver - January 21, 2021 Bugs and slimes – or protein for modern times? Current agricultural practices are considered by many to be unsustainable for a number of reasons. ...
Simon Kremer - January 7, 2021 Save our staples: Securing the future of food Rising global temperatures and rising populations threaten farmers’ ability to grow the crops we ...
Eliot Ward - December 21, 2020 Will the COVID-19 vaccines induce more robust immunity than infection with SARS-Cov-2 itself? Respiratory viruses such as coronaviruses are notorious for evading the immune system[1] and, in ...
Camille Terfve - December 3, 2020 Deep learning cracks the protein folding problem? Deep learning has just made a new headline grabbing achievement: DeepMind’s latest AI-powered ...
Frances Salisbury - December 2, 2020 Go with the flow: the allure of the liquid biopsy Forward finds out how fresh technologies are providing a way to cut invasive procedures out of the ...
Adam Gregory - December 2, 2020 First regulatory approval for cultured meat – a major milestone In December 2020, US company Eat Just were granted regulatory approval by the Singapore Food Agency ...
Tanis Keirstead - November 27, 2020 Further constitutional challenges to Unified Patent Court Agreement On 26 November 2020, the German Bundestag approved the ratification bill for the Unified Patent ...
Nick Sutcliffe - November 25, 2020 AstraZeneca/Oxford University vaccine shows efficacy against SARS-CoV-2 AstraZeneca/Oxford University have announced that their SARS-CoV-2 candidate vaccine AZD1222 showed ...
Nick Sutcliffe - November 16, 2020 And then there were two – Moderna SARS-CoV-2 vaccine shows efficacy Moderna have announced that their SARS-CoV-2 vaccine candidate mRNA1273 showed efficacy in a first ...
Christopher Casley - November 13, 2020 Videoconference Oral Proceedings for EPO Oppositions – an Update The EPO has announced changes to the Pilot Project for Video Conference (ViCo) Oral Proceedings ...
Christopher Casley - November 13, 2020 EPO Zooming to catch-up UPDATE 6 APRIL 2022: On 6 April 2022, the EPO issued a notice extending its pilot project for ...
Nick Sutcliffe - November 13, 2020 Pfizer and BioNTech vaccine provides protection against SARS-CoV-2 Pfizer/BioNTech have now released more data from the Phase 3 clinical trial of the BNT162b2 ...
Frances Salisbury - November 5, 2020 MycoTechnology wins $1M in protein challenge, accelerating growth of mushroom fermentation platform Our client, MycoTechnology, has won the Radicle Growth Protein Challenge by Syngenta, earning the ...
Rebecca Tollervey - October 30, 2020 Highly-engineered antibodies: evolving the patent strategy In recent years, antibody engineering has moved into a new phase of complexity, with a ...
Joseph Newcombe - October 29, 2020 Personalising medicine based on gut reaction No, we are not talking about jumping to conclusions, but the reactions carried out by the gut ...
Adam Gregory - October 27, 2020 Hummingbird Bioscience to start clinical trials for SARS-CoV-2-targeted antibody, HMBD-115 Our client, Hummingbird Bioscience, has received regulatory authorisation to initiate clinical ...
Jacqueline Murphy - October 23, 2020 Chambers & Partners 2020 Legal Guide - Band 1 Recommended Firm We are pleased to report that Mewburn Ellis has been ranked Band 1 in Chambers & Partners 2020 ...
Jacqueline Murphy - October 22, 2020 MIP IP STARS: The Rising Stars in IP 2020 Congratulations to Rebecca Anderson-Smith, Callum McGuinn and Ben Tolley for being recognised as ...
Nick Sutcliffe - October 21, 2020 Liquid biopsies support precision medicine The treatment of cancer patients with therapies that are specifically targeted to their cancer is a ...
Katherine Green - October 9, 2020 Nobel Prize in Chemistry awarded for CRISPR "genetic scissors" In 2012, Jennifer Doudna and Emmanuelle Charpentier published their ground-breaking paper in ...
Anna Mudge - October 9, 2020 Minimally invasive, maximum potential: liquid biopsy is redefining diagnosis Many of us will know someone who has undergone a biopsy during a medical diagnosis: we may even ...
Jacqueline Murphy - October 1, 2020 Mewburn Ellis: top tier firm Legal 500 2021 We are delighted to be ranked top tier for our patent practice in the 2021 edition of The Legal ...
Fay Allen - September 24, 2020 More like the real meal - alternative plant-based proteins Plant-based protein alternatives have arrived in the UK in a big way, where sales of meat-free ...
Camille Terfve - September 24, 2020 Genomics medicine has already proved its potential: the (success) story of non-invasive prenatal testing We have previously discussed the tremendous progress made towards the adoption of genomics medicine ...
Nick Sutcliffe - September 22, 2020 Making the detection of cancer in liquid biopsies more sensitive Besides being found within the nucleus and mitochondria of cells, DNA is also present in ...
Adam Gregory - September 14, 2020 Trust at the dinner table: public perception and regulation of novel food technologies The history of humanity is the history of food technology. From the moment early hominids developed ...
Nick Sutcliffe - September 11, 2020 Pepper decision means conventionally bred plants and animals get a chilli reception at the EPO Dr Ben Tolley and Dr Nick Sutcliffe of the Life Sciences team look at the extensive ramifications ...
Frances Salisbury - September 10, 2020 Neoantigens: IP considerations for an emerging class of cancer immunotherapy Recent cell and gene therapy product approvals have allowed the pharmaceutical industry to start a ...
Jane Liu - September 2, 2020 The emergence of liquid biopsies as companion diagnostics The development of liquid biopsies The term liquid biopsy refers to the use of different body ...
Sarah Harvey - August 28, 2020 Outstanding in the field - Biotechnology and the search for improved crops At a time that the media is saturated with COVID-19 news, it can be easy to lose sight of other ...
Simon Kremer - August 28, 2020 Growing Underground: In the pink Forward editor Caitlin Mackesy Davies finds out why one of our best models for the future of food ...
Adam Gregory - August 27, 2020 Beyond cultured meat: Cellular Agriculture and animal products In recent months, lab-grown meat is getting a lot of attention. As environmental concerns and ...
Adam Gregory - August 24, 2020 Is the future of meat animal-free? Compelling advancements in cellular science could soon see us choosing to abandon animal ...
Katherine Green - August 21, 2020 Most Opposed Patents of 2019 The four thousand or so European patents that are opposed every year represent only about 3% of all ...
Simon Kiddle - August 20, 2020 Oppositions & Appeals: we helped clear a new path to patenting dosage regimes Case 10 – T 1020/03 (EPO Board of Appeal, 29 October 2004)
Simon Kiddle - August 7, 2020 A shore thing: eco-friendly seaweed materials It may be a bother for sunbathers, but seaweed is a promising eco-friendly industrial material.
Adam Gregory - August 3, 2020 Cellular Agriculture – forecasting innovation In their recent article in Nature Food, high-profile figures in the field of Cellular Agriculture – ...
Seán Walton - July 24, 2020 Oppositions & Appeals: novelty of a patient sub-population Case 9 – T 734/12 (EPO Board of Appeal, 17 May 2013)
Victoria Coleman - July 21, 2020 UK formally withdraws from the UPC In a statement to Parliament on 20 July 2020, the government formally confirmed the UK’s withdrawal ...
Chris Denison - July 21, 2020 Are functional foods worth the fuss? Forward: features discuss and celebrate the best of innovation and exploration from the scientific ...
Frances Salisbury - July 16, 2020 Five tips for patenting inventions in personalised and stratified medicine As medical treatments become increasingly bespoke, we reveal some best practices to ensure that you ...
Camille Terfve - July 14, 2020 Can software be therapeutic? The simple answer is: yes. Thanks for reading this post, stay tuned for more answers to your ...
Sean Jauss - July 14, 2020 String theory: how bundling IP rights strengthens bioinformatics products As part of our Thought Leaders series, Mewburn Ellis Partner Sean Jauss explores how bundling IP ...
Rachel Oxley - July 9, 2020 “Test, test, test” – the importance of diagnostics in pandemic preparedness While the world waits for a vaccine to be developed and approved for use against the COVID-19 ...
Camille Terfve - July 6, 2020 Protecting IP in bioinformatics and digital health: tips and tricks to tackle the “moving target problem” As previously discussed, data driven approaches have revolutionised research and R&D in the ...
Nick Sutcliffe - June 29, 2020 Supreme Court confirms strict line on insufficiency in the UK On 24 June 2020, the UK Supreme Court (UKSC) confirmed the UK courts’ strict approach to sufficient ...
Simon Kiddle - June 29, 2020 Oppositions & Appeals: we helped determine the meaning of “surgery” Case 8 – T 1695/07 (EPO Board of Appeal, 28 September 2011)
Rebecca Tollervey - June 25, 2020 Cellular immunity – a contributor to COVID-19 “dark matter”? Immunologist Karl Friston of University College London has theorized that there may be ...
Camille Terfve - June 23, 2020 A Guide to Patenting Bioinformatics Inventions at the EPO: what is technical and why does it matter? Many inventions in the field of bioinformatics (a term that we will use herein to encompass ...
Helen Bower - June 19, 2020 Financial Times: Europe's Leading Patent Law Firms 2020 We are delighted to once again be recognised in the Financial Times’ annual report on Europe’s ...
Jacqueline Murphy - June 16, 2020 IAM Patent 1000: The World’s Leading Patent Professionals 2020 We are delighted to once again be ranked ‘highly recommended’ in ‘IAM 1000: The World’s Leading ...
Sean Constable - June 10, 2020 Can CRISPR help us in the fight against COVID-19? As countries across the world continue to face widespread disruption in the face of the COVID-19 ...
Tanis Keirstead - June 5, 2020 Links between COVID-19 severity and the immune system The mechanism through which SARS-CoV-2, the virus that causes COVID-19, infects cells is known. The ...
Camille Terfve - June 3, 2020 Have we entered the era of the DIY superhuman? Self-improvement products are everywhere around us, on our bookshelves and supermarket shelves ...
Nick Sutcliffe - May 19, 2020 G3/19 The Enlarged Board of Appeal has its cake and eats it On 14 May 2020, the Enlarged Board of Appeal of the European Patent Office (EBA) released their ...
Simon Kiddle - May 18, 2020 Oppositions & Appeals: We helped shape the debate on medical use claim patentability Case 7 – T 879/12 (EPO Board of Appeal, 27 August 2014)
Adam Gregory - May 15, 2020 New coronavirus (COVID-19) test allows rapid detection of neutralising antibodies Our client, Duke-NUS, has helped to develop a new, rapid serological test for determining whether ...
Thomas Driver - May 14, 2020 BREAKING: G3/19 – an end to the plant patentability saga? On 14 May 2020, the Enlarged Boards of Appeal of the European Patent Office released their decision ...
Richard Clegg - May 14, 2020 Singapore's biotech breakthrough From the far east to the east coast of America, the world is taking note of a new energy surging ...
Joseph Newcombe - May 7, 2020 InVEntions of WWII VE day on Friday 8 May 2020 is the 75th anniversary of the end of WWII in Europe. In 1945 the day ...
Rhiannon Wescott - May 1, 2020 Can a functionally defined patent claim ‘protect’ my medicinal product? From a patent perspective this may seem like a strange question with an obvious answer; “of ...
Robert Andrews - April 30, 2020 BerGenBio’s bemcentinib selected for fast track as potential treatment for coronavirus (COVID-19) In the fight against the coronavirus pandemic, bemcentinib produced by BerGenBio has been selected ...
Simon Kiddle - April 27, 2020 Oppositions & Appeals: We moved the conversation on animal involvement Case 6 – T 1262/04 (EPO Board of Appeal, 13 July 2012)
Camille Terfve - April 23, 2020 Coronavirus (COVID-19), big data and silver linings There is no denying that the COVID-19 pandemic will have tremendous practical and economic impact ...
Adam Gregory - April 14, 2020 Antibody tests for prior infection with SARS-CoV-2 – key tools for monitoring and managing the coronavirus (COVID-19) outbreak In recent weeks there’s been a lot of discussion in the media of antibody tests relating to ...
Camille Terfve - April 6, 2020 What use is computational biology during the coronavirus (COVID-19) pandemic? There is one obvious way in which computational biology is showing its strengths in the current ...
Eliot Ward - April 2, 2020 A*STAR and MiRXES step up in the fight against coronavirus (COVID-19) Our Singapore based-clients A*STAR (Agency for Science, Technology and Research) and MiRXES are ...
Anna Mudge - March 31, 2020 Neoantigen-targeted adoptive cell therapies – the next frontier in cancer immunotherapy Cancer immunotherapies harness the power of the patient’s immune system to destroy malignant cells ...
Sean Constable - March 30, 2020 CRISPR used in gene editing clinical trial for first time The revolutionary CRISPR gene editing tool has been used inside the human body for the first time ...
Eliot Ward - March 25, 2020 Microbiome: Meet your multitude The health and wellbeing of each of us depends upon a number of vast communities of microbes that ...
Tanis Keirstead - March 24, 2020 Coronavirus (COVID-19): a case study in emerging disease UPDATE 14 APRIL 2022: In his blog Horizons in vaccine production, we explore pressing need to ...
Lucy White - March 23, 2020 Vaccine platform technologies to combat emerging infectious diseases The SARS-CoV-2 outbreak is now a global pandemic. In a previous post, we discussed the need to act ...
Camille Terfve - March 18, 2020 Bioinformatics - science's big secret Now deeply woven into the fabric of biological research, bioinformatics has become the secret sauce ...
Seán Walton - March 12, 2020 Oppositions & Appeals: We set the standard for the strawman Case 5 - T 649/92 (EPO Enlarged Board of Appeal, 2 July 1996)
Camille Terfve - March 9, 2020 Bioinformatics, data and healthcare: Benefits and challenges of data-driven medicine Algorithms (sometimes collectively referred to as ‘digital health’) are changing the way that ...
Katherine Green - February 24, 2020 EPO streamlining: the opposition timeline tightens Our analysis of patent oppositions has revealed that early action has become imperative for ...
Anna Mudge - February 19, 2020 What makes Massachusetts small but mighty? Deirdre Sanders, president of the Boston Patent Law Association and a principle at Hamilton Brook ...
Nick Sutcliffe - February 18, 2020 The evolutionary history of cancer - predicting the disease Cells can acquire the mutations that drive the development of cancer many years before the patient ...
Camille Terfve - February 14, 2020 Genomics and Biodata in 2020: the future is here! I have been working in the field of bioinformatics/computational biology for 10 years now and have ...
Richard Clegg - February 12, 2020 Oppositions & Appeals: we opened the door for different types of data to support a medical use Case 4 - T 801/06 (EPO Board of Appeal, 4 March 2009)
Camille Terfve - February 7, 2020 Genomics and Biodata in 2020: so much data, so little time? Having attended the Festival of Genomics & Biodata 2020 conference last week, it is clear that ...
Thomas Driver - February 6, 2020 Genetic engineering and synthetic biology – making cannabis production greener The therapeutic benefits of medicinal cannabis have been liberally splashed across newspaper ...
Adam Gregory - February 4, 2020 Enleofen strikes Singapore’s biggest ever biotech deal In January it was announced that global pharmaceutical company Boehringer Ingelheim has acquired ...
Maria Hall - February 3, 2020 Munich office expansion with high-profile lateral hire We are delighted to announce the high-profile appointment of Dr. Thomas Wolter into our Munich ...
Adam Gregory - January 30, 2020 Farming the great indoors When you think of a farm, what comes to mind? Rolling fields of green new growth, and carpets of ...
Katherine Collins - January 29, 2020 Advancements of genetic testing The sequencing of the first human genome in 2003 was a major breakthrough in genomics. While this ...
Simon Kiddle - January 29, 2020 Oppositions & Appeals: We made the case for a new technical effect Case 3 - T 1642/06 (EPO Board of Appeal, 23 August 2007)
Camille Terfve - January 23, 2020 Simulations in bioinformatics and the G1/19 referral What’s all this about? Claims directed to methods of simulation or modelling of a system or process ...
Sean Constable - January 17, 2020 EPO Board of Appeal confirms Broad Institute’s CRISPR patent lacks priority and upholds revocation decision In one of the most high profile cases of recent years, a European Patent Office (EPO) Board of ...
Camille Terfve - January 2, 2020 AI, deep learning and image analysis in bioinformatics Putting “AI” in the title of your paper, or indeed in the name of your company, seems to have ...
Anna Mudge - December 18, 2019 Will biomarkers come of age? The world’s population is ageing. In 2018, for the first time in history, people aged 65 or above ...
Camille Terfve - December 16, 2019 Bioinformatics: biological and medical sciences in the age of big data What is bioinformatics? Bioinformatics is a term which we will use as an umbrella to encompass work ...
Camille Terfve - December 16, 2019 Bioinformatics is everywhere! As discussed in a previous post, most types of biological or medical data that can be collected ...
Isobel Stone - December 16, 2019 Collagen scaffolds – the future of tissue engineering? Despite the success of organ transplantation since its inception in the 20th century, people today ...
Eliot Ward - December 6, 2019 Gamma/delta T cells emerge as an untapped resource for cancer immunotherapy Third lymphocyte lineage shows its mettle B lymphocytes, a type of white blood cell that is ...
Anna Mudge - November 27, 2019 Biomarkers and precision medicine A biomarker, an amalgamation of the term ‘biological marker’, is a measurable indicator of a ...
Richard Clegg - November 15, 2019 Meet the team: Richard Clegg, Partner, European Patent Attorney, Patent Attorney Litigator As part of our 'meet the team' series, we talk to Richard Clegg about his journey to becoming a ...
Maria Hall - November 14, 2019 New report launched: EPO Opposition Trends in the Life Sciences Sector Our new research has revealed several recent patterns regarding the European Patent Office ...
Katherine Green - November 14, 2019 EPO oppositions: Nine key questions answered Mewburn Ellis has dug deep into a decade of EPO life sciences' decisions to discover fresh insights ...
Chris Denison - November 12, 2019 Meet the team: Chris Denison, Partner, European Patent Attorney As part of our 'meet the team' series, we talk to Chris Denison about his journey to becoming a ...
Rebecca Tollervey - November 11, 2019 Top tips for patenting antibodies in Europe Antibody development is a mature field of technology. There are relatively few new targets, and the ...
Seán Walton - November 11, 2019 Oppositions a case to remember: we forced a fuller view of technical features Case 1 – T 1859/08 ( EPO Board of Appeal, 5 June 2016)
Simon Kiddle - November 8, 2019 Meet The Team: Simon Kiddle, Partner, European Patent Attorney As part of our 'meet the team' series, we talk to Simon Kiddle about his journey to becoming a ...
Katherine Green - November 5, 2019 Meet The Team: Katherine Green, Partner, European Patent Attorney As part of our 'meet the team' series, we talk to Katherine Green about her journey to becoming a ...
Camille Terfve - October 30, 2019 EPO Bioinformatics Roadshow There is still a relatively prevalent view in the field of bioinformatics and medical informatics ...
Katherine Green - October 30, 2019 Oppositions - a case to remember. Flexibility around added matter Case 2 – T 0099/13 (EPO Board of Appeal, 14 January 2016)
Emily Hayes - October 28, 2019 Meet The Team: Emily Hayes, Partner, European Patent Attorney As part of our 'meet the team' series, we talk to Emily Hayes about her journey to becoming a ...
Sean Constable - October 25, 2019 Employing CRISPR to expose ‘hiding’ cancer cells to immunotherapy Immunotherapy employs the patient’s immune system against cancer. There are various types of ...
Thomas Driver - October 23, 2019 Renewable energy – huge potential for biofuel innovation It has been widely reported in the media recently that we need to do more to address the way in ...
Nick Sutcliffe - October 21, 2019 Controlling genes – the new field of epitranscriptomics The human genome contains roughly 20,000 genes that encode proteins. In order for the cells and ...
Adam Gregory - September 26, 2019 T cell engagers - dark horses of immunotherapy Chimeric antigen receptor (CAR) technology has attracted a lot of attention and investment in ...
Tanis Keirstead - September 19, 2019 Obtaining patent protection for fermentation processes and products – the European perspective Fermented foods have been known for millennia and form an important part of many national cuisines. ...
Simon Kremer - September 11, 2019 Food of the future – regulating and protecting gene-edited crops A recent episode of the BBC World Service’s excellent series “50 Things that made the modern ...
Camille Terfve - September 4, 2019 DIY biology dilemma – regulating biohacking Science kits may have inspired generations of children to become scientists, and those grown up ...
Nick Sutcliffe - August 29, 2019 Shifting treatments: cancer as a manageable disease As new treatments drive a shift towards treating cancer as a manageable disease we are seeing ...
Camille Terfve - August 15, 2019 Patentable subject matter in bioinformatics - USPTO’s January 2019 guidance In this article, Paul Liu and Ashley Barton from Duane Morris LLP provided some interesting ...
Richard Clegg - August 13, 2019 Challenges Post Selex Twenty-five years ago Tuerk and Gold reported the Selex method. Being the first European patent ...
Frances Salisbury - August 5, 2019 The rise of predictive medicine Thanks to significant advances in genetics, we are not only getting better at diagnosing disease, ...
Adam Gregory - July 23, 2019 Cultured meat - food for thought Cultured meat is rapidly emerging alongside plant-and microorganism-based alternative meat products ...
Emily Hayes - July 9, 2019 New Rules of Procedure at the Boards of Appeal – what does this mean for patentees and opponents? Revised Rules of Procedure at the Boards of Appeal have been approved by The Administrative Council ...
Emily Hayes - July 5, 2019 A Myriad of effects Even though the decision in Myriad is now 6 years old and there have been several follow-on cases, ...
Frances Salisbury - June 26, 2019 Gender medicine – deriving novelty from treating women? When you hear the term “gender medicine”, what comes to mind? For many people, the term is ...
Adam Gregory - June 21, 2019 Singapore biotech start-ups: the importance of patent protection Singapore’s biotech industry plays a key role in shaping the country’s future economy. This is ...
Anna Mudge - June 19, 2019 Tips from the top: inspiring women in technology You may be surprised to hear that only 17% of those working in Technology in the UK are female. ...
Frances Salisbury - June 4, 2019 EU approves first gene therapy for patients with a mild form of β-Thalassemia Exciting news in the personalised medicine space – the EU has just approved the first gene therapy ...
Adam Gregory - May 17, 2019 Precision therapeutics for the precision medicine era In recent years we have seen dramatic advances in our understanding of the intricate and dynamic ...
Simon Kiddle - April 29, 2019 Personalised medicine: patient stratification While the general idea of customising treatment to patients is not new, the degree to which ...
Frances Salisbury - April 15, 2019 Pioneers of precision medicine Breakthroughs in healthcare promise a future in which the individual sits at the centre of medical ...
Julie Carlisle - March 28, 2019 Dosage regimen patents: bruised but not beaten Ruling on the big pharma Actavis v ICOS case, the UK Supreme Court has found ICOS’s Cialis patent ...
Emily Hayes - March 25, 2019 Playing for time: strategies that can help extend a drug's patent life In our new magazine Forward, we interview C Hunter Baker of Wolf, Greenfield & Sacks PC. Hunter ...
Sean Constable - March 6, 2019 EPO oral proceedings in Haar - do they infringe a party’s right to be heard? A new referral to the Enlarged Board raises this question... The right to be heard under Article ...
Frances Salisbury - February 27, 2019 Bioinformatics Inventions: Patenting challenges at the interface of computer and life sciences We are entering an age of precision medicine, with patients receiving tailored treatments, selected ...
Simon Kiddle - February 22, 2019 Is your interest legitimate? New referral to the EBOA on double patenting EPO Board of Appeal 3.3.01 is referring a number of questions regarding double patenting to the ...
Thomas Driver - February 6, 2019 Plant related inventions: clarity at last? As we reported previously, EPO Technical Board of Appeal 3304 recently ruled that a controversial ...
Frances Salisbury - February 4, 2019 Fighting cancer with CAR-T therapies In September 2018, NHS England entered into an agreement with Novartis to offer its CAR-T therapy, ...
Emily Hayes - January 30, 2019 Commercialising genomic research in the US: tips for obtaining patent protection The field of genomics has seen incredible advances over the past few decades. Technological ...
Frances Salisbury - January 30, 2019 China - a key player in the global precision medicine race With a growing economy, and a large, ageing population, China is attracting attention from global ...
Sean Jauss - January 14, 2019 Eight key themes from the J.P. Morgan Healthcare Conference I’ve spent the last few days talking with biotech entrepreneurs, VC fund managers and lawyers ...
Frances Salisbury - December 13, 2018 Precision medicine: ethics, regulation and patent law New genomic and proteomic analysis technologies allow for diagnosis and prognosis of patients with ...
Frances Salisbury - December 10, 2018 Plant related inventions: the saga continues We may be approaching the end of the year, but the saga of patents for plant related inventions at ...
Adam Gregory - December 10, 2018 Patent protection: five tips for biotech start-ups Early-stage biotech companies are often founded based on the exciting results of pre-clinical ...
Richard Clegg - December 10, 2018 Clovis Oncology success in European Opposition Proceedings related to Rubraca® Clovis Oncology has announced that the European Patent Office (EPO) last week upheld claims of ...
Anna Mudge - December 2, 2018 The importance of Innovation Hubs in the UK's North West Region Life science ‘start-ups’, ‘spin-outs’ and SMEs are some of the most innovative businesses and are ...
Nick Sutcliffe - November 14, 2018 Supreme Court decision signals bad news for patent holders The UK Supreme Court issued its decision today on the Warner Lambert vs Generics (UK) Ltd t/a ...
Frances Salisbury - October 31, 2018 Precision Medicine: the next revolution in healthcare In recent years, we have witnessed a remarkable healthcare revolution. Thanks to advances in ...
Richard Clegg - October 31, 2018 Morphosis: creating and nurturing biotech start-ups in Singapore We understand that early-stage biotech companies do not have it easy. It is a long road from ...
Seán Walton - October 3, 2018 The pioneering work of Professor Sir Greg Winter Professor Sir Greg Winter’s pioneering work using phage display for the directed evolution of ...
Simon Kremer - April 30, 2018 Changes to inter partes review system for challenging granted patents Last week, the U.S. Supreme Court issued two important decisions relating to inter partes review ...
